GlassScriptPhysician profile
Brett Michael Keck
NPI 1144466319
$39,719.92
in general payments reported to CMS, 2019-2025
24 companies · $5,579 in 2025
The $5,579 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.61 · 2020: $20.00 · 2022: $7,248 · 2023: $13K · 2024: $14K · 2025: $5,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $28K · Food and Beverage: $2,844 · Travel and Lodging: $1,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $28,000.00 |
| Food and Beverage | $2,844.29 |
| Travel and Lodging | $1,552.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $37,764.76 | 2022-2025 | Da Vinci Surgical System |
| Abbvie INC. | $449.76 | 2023-2025 | |
| Novo Nordisk INC | $278.69 | 2023-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $135.15 | 2024-2025 | Farxiga |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $127.38 | 2022-2025 | Caplyta |
| Lilly USA, LLC | $121.64 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Intuity Medical INC | $121.24 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Scilex Pharmaceuticals INC. | $110.46 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $102.95 | 2022-2025 | Gardasil 9, Capvaxive, Gardasil |
| Axsome Therapeutics, INC. | $61.66 | 2025 | Symbravo, Auvelity |
| Amgen INC. | $48.09 | 2022-2024 | Prolia, Evenity |
| Eisai INC. | $46.98 | 2022-2025 | |
| Abbott Laboratories | $45.67 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $45.60 | 2020-2025 | Spravato |
| Idorsia Pharmaceuticals US INC | $42.45 | 2023-2024 | Quviviq |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $42.05 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Medtronic USA, INC. | $36.43 | 2019 | |
| Exact Sciences Corporation | $25.64 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.54 | 2024 | Ofev |
| Dexcom, INC. | $19.97 | 2023 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $18.18 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.61 | 2022 | |
| Phathom Pharmaceuticals, INC. | $16.02 | 2025 | Voquezna |
| Vivus LLC | $16.00 | 2023 | Qsymia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Keck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.